No abstract available
MeSH terms
-
B-Cell Maturation Antigen
-
Cell- and Tissue-Based Therapy
-
Clinical Trials, Phase I as Topic
-
Humans
-
Immunotherapy, Adoptive / methods
-
Multiple Myeloma* / therapy
-
Neoplasms, Plasma Cell*
-
Receptors, Chimeric Antigen* / genetics
Substances
-
B-Cell Maturation Antigen
-
Receptors, Chimeric Antigen
Grants and funding
Funding: This work was supported by a grant from the Shanghai Strategic Emerging Industry Development Foundation and by CARsgen Therapeutics.